Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LHBETATAG retinoblastoma tumors

by Samuel K Houston, Yolanda Piña, Timothy G Murray, et al
Published 2011-01-01